CAS 86329-79-5

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, sodium salt (1:2), (6R,7R)-

Description:

The chemical substance known as "5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, sodium salt (1:2), (6R,7R)-" with CAS number 86329-79-5 is a complex bicyclic compound featuring a thiazole and thiazolidine moiety. This compound exhibits characteristics typical of antibiotic agents, particularly those that inhibit bacterial cell wall synthesis. Its structure includes multiple functional groups such as carboxylic acids, amines, and thioethers, which contribute to its biological activity. The presence of a sodium salt form indicates enhanced solubility in aqueous environments, making it suitable for pharmaceutical applications. The stereochemistry denoted by (6R,7R) suggests specific spatial arrangements of atoms that can influence the compound's interaction with biological targets. Overall, this compound is significant in medicinal chemistry, particularly in the development of antimicrobial therapies.

Formula: C₂₀H₂₀N₆O₇S₄·2Na

InChI: InChI=1S/C20H20N6O7S4.2Na/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9;;/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32);;/b25-12-;;/t13-,17-;;/m1../s1

InChI key: InChIKey=AFILJETUDYIPBX-AEKYOGSZSA-N

SMILES: C(O)(=O)C=1N2[C@@]([C@H](NC(/C(=N\OC)/C=3N=C(N)SC3)=O)C2=O)(SCC1CSC=4SC(CC(O)=O)=C(C)N4)[H].[Na]

Synonyms:

• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, disodium salt, [6R-[6α,7β(Z)]]-
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, disodium salt, (6R,7R)-
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[[5-(carboxymethyl)-4-methyl-2-thiazolyl]thio]methyl]-8-oxo-, sodium salt (1:2), (6R,7R)-
• 7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((5-(carboxymethyl)-4-methyl-2-thiazolyl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid disodium salt
• Cefodizime disodium
• Cefodizime disodium salt
• Hr 221
• Kenicef
• S 77-1221B
• Thr 221
• Timecef
• [7-[[(2E)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[[4-methyl-5-(2-oxo-2-sodiooxy-ethyl)thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyl]oxysodium

Cefodizime Disodium

CAS: 86329-79-5

Formula: C₂₀H₁₈N₆Na₂O₇S₄

Purity: 97%

Color and Shape: Solid

Molecular weight: 628.6325

Ref: IN-DA008ERV

Cefodizime Sodium

CAS: 86329-79-5

Cefodizime Sodium

Purity: ≥95%

Molecular weight: 628.6g/mol

Ref: 54-BUP14609

Cefodizime Sodium

CAS: 86329-79-5

Cefodizime Sodium

Purity: 98%

Molecular weight: 628.63g/mol

Ref: 54-OR1030375

Cefodizime Sodium

CAS: 86329-79-5

Cefodizime Sodium is a third generation cephalosporin antibiotic, has broad-spectrum activity

Formula: C₂₀H₁₈N₆Na₂O₇S₄

Purity: 97.1%

Color and Shape: White To Yellow Crystalline Powder

Molecular weight: 628.6

Ref: TM-T8126

Cefodizime Sodium

Controlled Product

CAS: 86329-79-5

Stability Hygroscopic
Applications Cefodizime Sodium (cas# 86329-79-5) is a compound useful in organic synthesis.

Formula: C₂₀H₁₈N₆Na₂O₇S₄

Color and Shape: Neat

Molecular weight: 628.63

Ref: TR-C242883

Cefodizime sodium

CAS: 86329-79-5

Cefodizime sodium is a third-generation cephalosporin antibiotic. It is indicated for the treatment of bacterial infections in the skin, soft tissue, respiratory tract, and urinary tract. Cefodizime sodium prevents bacteria from multiplying by inhibiting cell wall synthesis and DNA replication. Cefodizime sodium has been shown to be effective against Staphylococcus aureus and Proteus mirabilis. However, it is not active against Enterobacteriaceae or Pseudomonas aeruginosa. The drug can cause drug reactions such as fever and rash in some patients.br>br>Cefodizime sodium is given intravenously or intramuscularly in combination with glucose injection for the treatment of bacterial infection. The drug should be diluted with hydrochloric acid before administration to prevent irritation to tissue.br>br>Cefodizime sodium is also administered intravenously or intramuscularly as

Formula: C₂₀H₁₈N₆Na₂O₇S₄

Purity: Min. 95%

Molecular weight: 628.64 g/mol

Ref: 3D-FC41182